Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Sales/Maturities of Investments

$14.50M

Quarterly · Period ending: · USD

LCTX logo

LCTX Sales/Maturities of Investments

Latest reported$14.50M
LCTX Quarterly Sales/Maturities of Investments ($0.00 → $14.50M)
High-resolution chart · PNG

LCTX sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
14,495,000
5,965,000
0
0
0
2,000,000
3,000,000
4,000,000
18,000
0
9,833,000
6,029,000
24,332,000
23,332,000
0
0
0
0
0
0
0
0
-16,700,000
214,000
0
5,221,000
660,000
13,555,000
0
0
0
0
0
0
-8,898,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.